News

May 21, 2015May 28, 2015

Oxidized LDL Detection May Lead to the Development of New Hepatitis C Therapy

Hepatitis C, News

Findings from a new study recently published in the journal Cellular and Molecular Gastroenterology and Hepatology, the official journal American Gastroenterological Association, determined that a novel blood test is able ... Read more

May 19, 2015May 19, 2015

Hepatitis B Virus Researchers Make Important Discovery in the Field of Immunology

Hepatitis B, News

This week, a group of interdisciplinary researchers from the University College London (UCL) released study findings in which they made a discovery that could have important implications in several clinical disciplines. The ... Read more

May 14, 2015May 14, 2015

Diabetes Increases Risk For Hepatocellular Carcinoma In Adults With Hepatitis B Virus

Hepatitis B, News

Taiwanese patients suffering with chronic hepatitis B virus infection (HBV) and recently diagnosed with diabetes had a higher risk of developing hepatocellular carcinoma, according to recent findings published in the Alimentary Pharmacology and Therapeutics ... Read more

May 7, 2015May 12, 2015

Study Reveals a Promising Hepatitis E Virus Vaccine that Can Be Potentially Administered during Pregnancy

Hepatitis E, News

Researchers at the National Institute of Virology in India recently published in the Virology Journal that their experimental vaccine against hepatitis E virus (HEV) infection yielded encouraging results in terms ... Read more

May 5, 2015May 5, 2015

New Drug Shows Promise In Treating Chronic HCV Patients With Liver Transplant And Advanced Liver Disease

Hepatitis C, News

Hepatitis C is one of the worst forms of liver diseases affecting people in the world today — around 3.2 million have HCV in the United States alone. Spread mostly from ... Read more

May 1, 2015May 1, 2015

ALLY-1 Clinical Trial Results Suggest Viable Chronic Hepatitis C Virus Treatment

Hepatitis C, News

In a recent press release from Bristol-Myers Squibb, officials announced the success of their ongoing phase III clinical trial, ALLY-1, in meeting its predicted end-points. The trial had been conducted among ... Read more

April 30, 2015April 30, 2015

Study Reveals Hepatitis E Vaccine Can Protect Up to 4.5 Years

Hepatitis E, News

A new study conducted by a research group in China assessed a vaccine for Hepatitis E. The vaccine caused the production of antibodies and protected vaccine recipients from hepatitis E for up to ... Read more

April 29, 2015April 29, 2015

UK Report Makes Important Discovery Shows That Global Hepatitis B Epidemic Can Be Treated for $36 Per Person Per Year

Hepatitis B, News

Researchers from the University of Liverpool have recently released results from a report in which they analyzed the factors that influence the cost of manufacturing drugs for the Hepatitis B ... Read more

April 28, 2015April 28, 2015

Gilead’s Drugs Harvoni and Sovaldi Prove to Be Safe and Effective in Patients with Advanced Liver Disease Associated with HCV

Hepatitis C, News

Gilead Sciences, Inc. recently announced in a press release the promising results from several Phase 2 clinical trials assessing the use of Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg) and Sovaldi® (sofosbuvir ... Read more

April 27, 2015April 27, 2015

Direct Antiviral Agents Significantly Decreases Hepatitis C Recurrence After Liver Transplantation

Hepatitis C, News

During the 50th International Liver Congress 2015 held in Vienna 22-26 of April in Austria, it was revealed that sofosbuvir (SOF)- and daclatasvir (DCV)-based regimens showed excellent results in patients with ... Read more